Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ernesto Vigna"'
Autor:
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Antonino Neri, Fortunato Morabito, Ernesto Vigna, Massimo Gentile
Publikováno v:
Expert Opinion on Investigational Drugs. 32:271-276
Autor:
Enrica Antonia Martino, Antonella Bruzzese, Ernesto Vigna, Enrico Iaccino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Gianfranco Filippelli, Antonino Neri, Fortunato Morabito, Massimo Gentile
Publikováno v:
Expert Opinion on Pharmacotherapy. 24:545-549
Autor:
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Carlo Bova, Gianfranco Filippelli, Isabella Capodanno, Antonino Neri, Fortunato Morabito, Massimo Gentile, Ernesto Vigna
Publikováno v:
European Journal of Haematology. 110:490-497
Autor:
Antonella Bruzzese, Daniele Derudas, Monica Galli, Enrica Antonia Martino, Stefano Rocco, Concetta Conticello, Catello Califano, Nicola Giuliani, Silvia Mangiacavalli, Giuliana Farina, Alessandra Lombardo, Marino Brunori, Elena Rossi, Elisabetta Antonioli, Roberto Ria, Renato Zambello, Nicola Di Renzo, Giuseppe Mele, Gianpaolo Marcacci, Giuseppe Pietrantuono, Gaetano Palumbo, Nicola Cascavilla, Claudio Cerchione, Angelo Belotti, Clelia Criscuolo, Giuseppina Uccello, Paola Curci, Ernesto Vigna, Francesco Mendicino, Enrico Iaccino, Selena Mimmi, Cirino Botta, Donatella Vincelli, Nicola Sgherza, Angela Bonalumi, Luca Cupelli, Raffaella Stocchi, Massimo Martino, Stelvio Ballanti, Dominella Gangemi, Alfredo Gagliardi, Barbara Gamberi, Alessandra Pompa, Giovanni Tripepi, Ferdinando Frigeri, Ugo Consoli, Sara Bringhen, Elena Zamagni, Francesca Patriarca, Valerio De Stefano, Francesco Di Raimondo, Salvatore Palmieri, Maria Teresa Petrucci, Massimo Offidani, Pellegrino Musto, Mario Boccadoro, Michele Cavo, Antonino Neri, Fortunato Morabito, Massimo Gentile
Publikováno v:
Hematological Oncology. 40:704-715
The combination of elotuzumab, lenalidomide, and dexamethasone (EloRd) enhanced the clinical benefit over Rd with a manageable toxicity profile in the ELOQUENT-2 trial, leading to its approval in relapsed/refractory multiple myeloma (RRMM). The prese
Autor:
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Rosanna Mazzulla, Silvia De Rose, Pietro Pasquale Cozza, Carlo Bova, Gianfranco Filippelli, Francesco Zinno, Michele Morelli, Fortunato Morabito, Massimo Gentile
Publikováno v:
Blood Coagulation & Fibrinolysis. 34:215-217
Autor:
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Carlo Bova, Angelo Barbato, Gianfranco Filippelli, Isabella Capodanno, Antonino Neri, Fortunato Morabito, Massimo Gentile
Publikováno v:
Hematological Oncology.
Autor:
Uros Markovic, Ernesto Vigna, Francesco Grimaldi, Giulia Palazzo, Antonio M. Risitano, Massimo Martino, Maria Cristina Pirosa, Giuseppe Milone, Stefania Stella, Giovanni Pisapia, Angelo Curto Pelle, Raffaele Palmieri, Luca Scalise, Francesco Di Raimondo, Stefania Tringali, Salvatore Leotta, Giulio Antonio Milone, Valerio Leotta, Fausto Palmieri, Paola Carluccio, Mary Ann Di Giorgio, Giorgina Specchia, Anna Bulla, Mario Annunziata
Publikováno v:
Annals of Hematology. 100:1743-1753
The experience of third-generation tyrosine kinase inhibitor ponatinib treatment in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph'+ ALL) patients post-allogeneic transplantation is limited. We retrospectively collected data on 25
Autor:
Enrica Antonia Martino, Concetta Conticello, Elena Zamagni, Vincenzo Pavone, Salvatore Palmieri, Maurizio Musso, Paola Tacchetti, Anna Mele, Lucio Catalano, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Cirino Botta, Iolanda Donatella Vincelli, Giuliana Farina, Marialucia Barone, Clotilde Cangialosi, Katia Mancuso, Ilaria Rizziello, Serena Rocchi, Antonietta Pia Falcone, Giuseppe Mele, Giovanni Reddiconto, Bruno Garibaldi, Enrico Iaccino, Giovanni Tripepi, Barbara Gamberi, Francesco Di Raimondo, Pellegrino Musto, Antonino Neri, Michele Cavo, Fortunato Morabito, Massimo Gentile
Publikováno v:
Hematological oncologyREFERENCES. 40(5)
In combination with lenalidomide and dexamethasone (KRd), Carfilzomib has been approved for the treatment of relapsed and refractory multiple myeloma (RRMM) on ASPIRE trial. Efficacy and safety of the triplet are still the object of investigation by
Autor:
Sara Galimberti, Mohammed Abu-Rayyan, Anna Grazia Recchia, Giovanna Cutrona, Cirino Botta, Moien Atrash, Lucio Morabito, Massimo Gentile, Ernesto Vigna, Mamdouh Skafi, Hamdi Al-Janazreh, Massimo Martino, Fortunato Morabito
Publikováno v:
Expert Opinion on Pharmacotherapy. 21:29-38
Introduction: Regimens involving intensive immuno-chemotherapy, followed by high-dose therapy and autologous stem cell transplant represent the standard treatment for younger fit patients with mantle cell lymphoma (MCL). Targeted approaches (i.e. ibr
Autor:
Cristina Santoro, Michele Morelli, Massimo Gentile, Ernesto Vigna, Antonietta Ferretti, Daniele Caracciolo, Erminia Baldacci, Brunella Muto, Enrica Antonia Martino, Francesco Mendicino, Cirino Botta, Eugenio Lucia
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia (platelet count
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d14d279199e9448d6802ada7e0bb1f3
http://hdl.handle.net/10447/518559
http://hdl.handle.net/10447/518559